Back to Journals » OncoTargets and Therapy » Volume 9

Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer

Total article views   HTML views PDF downloads Totals
8,772 Dovepress* 6,926+ 1,411 8,337
PubMed Central* 1,846 311 2,157
Totals 8,772 1,722 10,494
*Since 8 June 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar